Please use this identifier to cite or link to this item: https://islhd.intersearch.com.au/islhdjspui/handle/1/6161
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTierney Michael-
dc.date.accessioned2024-04-03T02:24:47Z-
dc.date.available2024-04-03T02:24:47Z-
dc.date.issued2024-03-20-
dc.identifier.urihttps://islhd.intersearch.com.au/islhdjspui/handle/1/6161-
dc.descriptionOrsiro is a stent platform that has ultrathin struts and a bioabsorbable polymer. As such it is theorised to have low late stent thrombosis rates. BIOSTEMI (the orsiro STEMI trial) has just published its 5 year results. We did Oriso for all STEMI from 2019-2022 Dec and hence have near 5 year follow up. Retrospective review of all STEMIen
dc.subjectMedicine-
dc.subjectCardiology-
dc.titleOrsiro DES - real-life comparison to 5 year trial data-
dc.contributor.islhdTierney, Michael-
local.contributor.leadinvestigatorMichael Tierney-
local.contributor.contactnameMichael Tierney-
local.description.timecommitment3 months. 4 hours per week-
local.identifier.joblevelJMO x2-
local.subject.specificskillsNone-
local.subject.specifictasksData collection-
local.subject.specifictasksData analysis and interpretation-
local.subject.specifictasksCreate Abstract for ANZET 2025 - due March 2025-
local.identifier.statusOpen-
local.contributor.contactemailmichael.tierney@health.nsw.gov.au-
Appears in Collections:Projects

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.